Literature DB >> 20376716

Medical research at the Albert Schweitzer Hospital.

Saadou Issifou1, Ayola A Adegnika, Bertrand Lell.   

Abstract

Built in 1981, the Medical Research Unit is located at the campus of the Albert Schweitzer Hospital. The main scientific activities of this research unit lie on clinical research focusing on antimalarial drugs and vaccines, and basic studies on pathogenesis of infectious diseases. Since 2002 the Medical Research Unit has experience in organising and hosting high quality training in clinical research in collaboration with the Vienna School of Clinical Research and other partners. For the future, this unit is involved as a key partner in the Central African Network on Tuberculosis, HIV/AIDS and Malaria (CANTAM) consortium playing a central role for the excellence in clinical research in Central Africa.

Entities:  

Mesh：

Year:  2010        PMID： 20376716     DOI： 10.1007/s00508-010-1327-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


  16 in total

1.  Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.

Authors:  Michael Ramharter; Sunny Oyakhirome; Peter Klein Klouwenberg; Ayola A Adégnika; Sélidji T Agnandji; Michel A Missinou; Pierre-Blaise Matsiégui; Benjamin Mordmüller; Steffen Borrmann; Jürgen F Kun; Bertrand Lell; Sanjeev Krishna; Wolfgang Graninger; Saadou Issifou; Peter G Kremsner
Journal:  Clin Infect Dis       Date:  2005-05-03       Impact factor: 9.079

2.  Malaria chemoprophylaxis with tafenoquine: a randomised study.

Authors:  B Lell; J F Faucher; M A Missinou; S Borrmann; O Dangelmaier; J Horton; P G Kremsner
Journal:  Lancet       Date:  2000-06-10       Impact factor: 79.321

3.  Blood group A antigen is a coreceptor in Plasmodium falciparum rosetting.

Authors:  A Barragan; P G Kremsner; M Wahlgren; J Carlson
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children.

Authors:  Steffen Borrmann; Ayola A Adegnika; Pierre-Blaise Matsiegui; Saadou Issifou; Andreas Schindler; Denise P Mawili-Mboumba; Thomas Baranek; Jochen Wiesner; Hassan Jomaa; Peter G Kremsner
Journal:  J Infect Dis       Date:  2004-02-16       Impact factor: 5.226

5.  Prognostic value of circulating pigmented cells in African children with malaria.

Authors:  Peter Gottfried Kremsner; Clarissa Valim; Michel A Missinou; Christopher Olola; Sanjeev Krishna; Saadou Issifou; Maryvonne Kombila; Lloyd Bwanaisa; Sadik Mithwani; Charles R Newton; Tsiri Agbenyega; Margaret Pinder; Kalifa Bojang; David Wypij; Terrie Taylor
Journal:  J Infect Dis       Date:  2009-01-01       Impact factor: 5.226

6.  Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.

Authors:  Martin P Grobusch; Bertrand Lell; Norbert G Schwarz; Julian Gabor; Jenny Dornemann; Marc Potschke; Sunny Oyakhirome; Georg C Kiessling; Magdalena Necek; Matthias U Langin; Peter Klein Klouwenberg; Anna Klopfer; Benjamin Naumann; Handan Altun; Selidji T Agnandji; Julia Goesch; Marieluise Decker; Carmen L Ospina Salazar; Christian Supan; Davy U Kombila; Lea Borchert; Kai B Koster; Peter Pongratz; Akim A Adegnika; Isabelle von Glasenapp; Saadou Issifou; Peter G Kremsner
Journal:  J Infect Dis       Date:  2007-10-25       Impact factor: 5.226

7.  Fosmidomycin for malaria.

Authors:  Michel A Missinou; Steffen Borrmann; Andreas Schindler; Saadou Issifou; Ayola A Adegnika; Pierre-Blaise Matsiegui; Ronald Binder; Bertrand Lell; Jochen Wiesner; Thomas Baranek; Hassan Jomaa; Peter G Kremsner
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

8.  Quinine plus clindamycin improves chemotherapy of severe malaria in children.

Authors:  P G Kremsner; P Radloff; W Metzger; E Wildling; B Mordmüller; J Philipps; L Jenne; M Nkeyi; J Prada; U Bienzle
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

9.  Assessment of volume depletion in children with malaria.

Authors:  Timothy Planche; Myriam Onanga; Achim Schwenk; Arnaud Dzeing; Steffen Borrmann; Jean-François Faucher; Antony Wright; Les Bluck; Leigh Ward; Maryvonne Kombila; Peter G Kremsner; Sanjeev Krishna
Journal:  PLoS Med       Date:  2004-10-19       Impact factor: 11.069

10.  Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria.

Authors:  Anelia Dietmann; Peter Lackner; Raimund Helbok; Katharina Spora; Saadou Issifou; Bertrand Lell; Markus Reindl; Peter G Kremsner; Erich Schmutzhard
Journal:  Malar J       Date:  2008-12-15       Impact factor: 2.979
View more
  1 in total

1.  Randomized, controlled, assessor-blind clinical trial to assess the efficacy of single- versus repeated-dose albendazole to treat ascaris lumbricoides, trichuris trichiura, and hookworm infection.

Authors:  Ayola A Adegnika; Jeannot F Zinsou; Saadou Issifou; Ulysse Ateba-Ngoa; Roland F Kassa; Eliane N Feugap; Yabo J Honkpehedji; Jean-Claude Dejon Agobe; Hilaire M Kenguele; Marguerite Massinga-Loembe; Selidji T Agnandji; Benjamin Mordmüller; Michael Ramharter; Maria Yazdanbakhsh; Peter G Kremsner; Bertrand Lell
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.